Aviva PLC Halozyme Therapeutics, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Aviva PLC holds 98,648 shares of HALO stock, worth $4.71 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

98,648

Previous 35,815 175.44%

Holding current value

$4.71 Million

Previous $1.88 Million 200.96%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $3.22 Million - $4.05 Million	62,833 Added 175.44%	98,648 $5.64 Million
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $678,012 - $844,495	20,131 Added 128.35%	35,815 $1.46 Million
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $91,763 - $115,943	2,754 Added 21.3%	15,684 $579,000
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $20,964 - $25,317	-575 Reduced 4.26%	12,930 $493,000
Q2 2023 Aug 10, 2023	BUY	$30.28 - $38.74 $86,691 - $110,912	2,863 Added 26.9%	13,505 $487,000
Q1 2023 May 12, 2023	BUY	$32.86 - $55.7 $53,101 - $90,011	1,616 Added 17.9%	10,642 $406,000
Q4 2022 Feb 09, 2023	SELL	$40.06 - $59.44 $146,739 - $217,728	-3,663 Reduced 28.87%	9,026 $514,000
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $116,206 - $156,168	3,016 Added 31.18%	12,689 $502,000
Q2 2022 Aug 04, 2022	BUY	$37.35 - $48.3 $361,286 - $467,205	9,673 New	9,673 $426,000
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $1.87 Million - $2.44 Million	-47,332 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$25.81 - $43.62 $990,278 - $1.67 Million	-38,368 Reduced 44.77%	47,332 $2.02 Million
Q3 2020 Nov 12, 2020	SELL	$25.74 - $29.63 $70,862 - $81,571	-2,753 Reduced 3.11%	85,700 $2.25 Million
Q2 2020 Aug 13, 2020	SELL	$16.25 - $26.81 $1.85 Million - $3.06 Million	-114,004 Reduced 56.31%	88,453 $2.37 Million
Q1 2020 May 14, 2020	BUY	$13.9 - $21.83 $2.81 Million - $4.42 Million	202,457 New	202,457 $3.64 Million

Others Institutions Holding HALO

# of Institutions

544

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.66B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account